Industry News

New research finds that recurrent head and neck tumors have gene mutations that could be vulnerable to the cancer drug dasatinib.

Immunovaccine reports enhanced cancer vaccine combination therapies at 2014 AACR Annual Meeting.

Sanofi and Genzyme to resubmit FDA application for approval of Lemtrada, for the treatment of relapsing forms of multiple sclerosis.

Novartis delivers 2 million treatments of its pediatric antimalarial to Zambia in collaboration with Malaria No More's Power of One campaign.

Vetter launches new serialization process to support track-and-trace efforts.

RCA opens a new office in Warsaw, Poland.

XstalBio Analytics' approach to vaccine analysis and formulation is aimed at understanding the antigen– adjuvant interaction.

FDA approves Xolair (omalizumab) for the treatment of a rare skin disease known as chronic idiopathic urticarial.

Walker Barrier Systems builds eight mobile clean rooms for the Texas A&M Center for Innovation in Advanced Development and Manufacturing.

Almac expands technical, project, and operational resources in Asia.

Johnson Controls launches Integrated Laboratory Services for R&D facility operations and scientific productivity.

CPhI report shows R&D market diversifying with increased partnerships, mergers, and revenue sharing models.

Cobra Biologics and BioCancell announce an agreement to manufacture BioCancell's BC-821 cancer drug.

Waters celebrates ten&$45;year anniversary of the ACQUITY UPLC System.

FDA approves the orphan drug Myalept for the treatment of leptin deficiency.

Novartis provides its second US university with Bexsero for the treatment of meningitis B.

Elanco acquires Germany-based Lohmann Animal Health.

Conference sessions, keynote events, exhibits, and poster sessions cover different aspects of bioprocessing.

Ecolab's Shield Medicare division will now be called Ecolab Contamination Control.

Agilent Technologies and Cell Line Genetics will collaborate on services for regenerative medicine and cancer research.

Debiopharm acquires Affinium's clinical and preclinical assets and its technology platform.

Cobra Biologics' GMP Compliance Certification has been extended to include QC testing.

Shimadzu's new Solution Center features additional research space.

Cytovance Biologics continues to work on the expansion of a manufacturing operations and GMP warehousing facility in Oklahoma.

Shimadzu's new Solution Center features additional research space.

Aesica appoints Ian Muir to the newly created position of commercial managing director.

Sartorius appoints Michael Melingo to head marketing, sales, and services of the Lab Products & Services Division.

FDA plans to issue a number of new guidances in 2014 that will address drug development and manufacturing practices.